Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple Myeloma
Clinical trial NCT00932698 · COMPLETED
Trial details
- NCT number
- NCT00932698
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-12
- Primary completion
- 2013-06-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.